FOR IMMEDIATE RELEASE
12-8-2005 Contact: Daryl Risinger 805.562.0511 Inogen to Present at Wall Street Conference, Harris Nesbitt’s Fourth Annual Healthcare Event
Company to Highlight its Opportunity to Garner Market Share and Grow Revenues
Rapidly with its Innovative Single Solution for Oxygen Patients
Santa Barbara, Calif., December 8, 2005 - Inogen, Inc. today announced that it will
participate in a Wall Street institutional investor event sponsored by investment bank
Harris Nesbitt. Harris Nesbitt’s 4th annual conference on the Healthcare industry, held on
Wednesday, December 8 at The Millennium Broadway Hotel in New York City, brings
together more than 50 leading and emerging companies in the life sciences and medical
technology industries.
Inogen CEO Kathy Odell, who will speak at the conference, said, "Inogen has a tremendous
opportunity to rapidly gain market share with our innovative single solution for oxygen
patients. At the conference, I will convey how Inogen plans to capitalize on the growing,
underserved Chronic Obstructive Pulmonary Disease (COPD) market and the clinical shift
to long-term oxygen therapy, ambulatory (active) therapy in particular. In addition, I will
highlight how Inogen will address both increasing oxygen patient demands and the need
of our customers, home healthcare providers, to improve margins after experiencing
tremendous financial pressure from reimbursement cuts."
Please contact Inogen for more information.
About Inogen
Santa Barbara, Calif.-based Inogen was founded in 2001 to develop products that improve quality of life while increasing freedom and mobility for respiratory disease sufferers, primarily sufferers of COPD. Inogen has assembled a team of experienced healthcare entrepreneurs, skilled technologists, well-known clinicians and home healthcare veterans to produce innovative solutions to respiratory healthcare challenges. The Inogen team is passionate about their mission and committed to serving the unique needs of respiratory patients and providers. To learn more about Inogen, please visit www.inogen.net.
###
|
|
|
|
|
